CD4 and colorectal cancer: Extracellular vesicles derived from LGG improved anti-PD-1 immunotherapy efficacy against colorectal cancer by increasing the CD8+ T/CD4+ T cell ratio in mesenteric lymph nodes and enhancing the ratio of MHC II+ DC cells, CD4+ T cells, and CD8+ T cells in tumor tissues.